Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure
- 2 October 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (11) , D14-D21
- https://doi.org/10.1016/0002-9149(90)90472-d
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failureThe American Journal of Cardiology, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart FailureAnnals of Internal Medicine, 1987
- Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.Heart, 1985
- Role of angiotensin II in the altered renal function of congestive heart failure.Circulation Research, 1984
- Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failureClinical Pharmacology & Therapeutics, 1984
- Effect of captopril on renal function in patients with congestive heart failure.Heart, 1981
- Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation, 1981
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.Circulation Research, 1979